REPORT ID 6768

Global Somatostatin Market Research Report 2017

Publish Date
1-Nov-17
Pages
116
Format
Electronic (PDF)

In this report, the global Somatostatin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Somatostatin in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Somatostatin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Merck (Schweiz) AG
    SANOFI-AVENTIS FRANCE
    Lyomark Pharma GmbH
    ALFA WASSERMANN S.p.A.
    Polypeptide Laboratories, Inc
    SAMARTH
    UBPL
    HYBIO
    TianTaiShan
    Yangtze River
    Siyao
    Shuangcheng
    Hainan Zhonghe
    SL PHARM
    Wuhan Hualong
    Qingdao Guoda
    Chengdu Shengnuo
    Longjin
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    0.25 mg/pcs
    0.75 mg/pcs
    3 mg/pcs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Somatostatin for each application, including
    Hospitals
    Drugstores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Somatostatin Market Research Report 2017
1 Somatostatin Market Overview
    1.1 Product Overview and Scope of Somatostatin
    1.2 Somatostatin Segment by Type (Product Category)
        1.2.1 Global Somatostatin Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Somatostatin Production Market Share by Type (Product Category) in 2016
        1.2.3 0.25 mg/pcs
        1.2.4 0.75 mg/pcs
        1.2.5 3 mg/pcs
    1.3 Global Somatostatin Segment by Application
        1.3.1 Somatostatin Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Drugstores
    1.4 Global Somatostatin Market by Region (2012-2022)
        1.4.1 Global Somatostatin Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Somatostatin (2012-2022)
        1.5.1 Global Somatostatin Revenue Status and Outlook (2012-2022)
        1.5.2 Global Somatostatin Capacity, Production Status and Outlook (2012-2022)

2 Global Somatostatin Market Competition by Manufacturers
    2.1 Global Somatostatin Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Somatostatin Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Somatostatin Production and Share by Manufacturers (2012-2017)
    2.2 Global Somatostatin Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Somatostatin Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Somatostatin Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Somatostatin Market Competitive Situation and Trends
        2.5.1 Somatostatin Market Concentration Rate
        2.5.2 Somatostatin Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Somatostatin Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Somatostatin Capacity and Market Share by Region (2012-2017)
    3.2 Global Somatostatin Production and Market Share by Region (2012-2017)
    3.3 Global Somatostatin Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Somatostatin Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Somatostatin Consumption by Region (2012-2017)
    4.2 North America Somatostatin Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Somatostatin Production, Consumption, Export, Import (2012-2017)
    4.4 China Somatostatin Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Somatostatin Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Somatostatin Production, Consumption, Export, Import (2012-2017)
    4.7 India Somatostatin Production, Consumption, Export, Import (2012-2017)

5 Global Somatostatin Production, Revenue (Value), Price Trend by Type
    5.1 Global Somatostatin Production and Market Share by Type (2012-2017)
    5.2 Global Somatostatin Revenue and Market Share by Type (2012-2017)
    5.3 Global Somatostatin Price by Type (2012-2017)
    5.4 Global Somatostatin Production Growth by Type (2012-2017)

6 Global Somatostatin Market Analysis by Application
    6.1 Global Somatostatin Consumption and Market Share by Application (2012-2017)
    6.2 Global Somatostatin Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Somatostatin Manufacturers Profiles/Analysis
    7.1 Merck (Schweiz) AG
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Somatostatin Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Merck (Schweiz) AG Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 SANOFI-AVENTIS FRANCE
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Somatostatin Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 SANOFI-AVENTIS FRANCE Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Lyomark Pharma GmbH
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Somatostatin Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Lyomark Pharma GmbH Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 ALFA WASSERMANN S.p.A.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Somatostatin Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 ALFA WASSERMANN S.p.A. Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Polypeptide Laboratories, Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Somatostatin Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Polypeptide Laboratories, Inc Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 SAMARTH
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Somatostatin Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 SAMARTH Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 UBPL
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Somatostatin Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 UBPL Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 HYBIO
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Somatostatin Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 HYBIO Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 TianTaiShan
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Somatostatin Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 TianTaiShan Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Yangtze River
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Somatostatin Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Yangtze River Somatostatin Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Siyao
    7.12 Shuangcheng
    7.13 Hainan Zhonghe
    7.14 SL PHARM
    7.15 Wuhan Hualong
    7.16 Qingdao Guoda
    7.17 Chengdu Shengnuo
    7.18 Longjin

8 Somatostatin Manufacturing Cost Analysis
    8.1 Somatostatin Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Somatostatin

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Somatostatin Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Somatostatin Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Somatostatin Market Forecast (2017-2022)
    12.1 Global Somatostatin Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Somatostatin Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Somatostatin Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Somatostatin Price and Trend Forecast (2017-2022)
    12.2 Global Somatostatin Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Somatostatin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Somatostatin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Somatostatin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Somatostatin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Somatostatin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Somatostatin Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Somatostatin Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Somatostatin Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer